Trastuzumab

Powder for concentrate for solution for infusion

Hertisan contains the active substance Trastuzumab, a “monoclonal antibody” that is designed to bind selectively to an antigen called human epidermal growth factor receptor 2 (HER2). When it binds to HER2 it stops the growth of such cells and causes them to die.

Hertisan is used in the treatment of breast cancer when:

• You have early breast cancer, with high levels of a protein called HER2.
• You have metastatic breast cancer with high levels of HER2, in combination with chemotherapy medicine.

Hertisan is used in the treatment of gastric cancer when:

• You have metastatic gastric cancer with high levels of HER2, in combination with the other cancer medicines.

Disclaimer: Items covered by valid patents not offered or supplied for commercial sale. Patent position should be verified by the buyer in the territory :تنويه المستحضرات المشمولة ببراءات اختراع مسجلة، غير معروضة ولا يتم تزويدها من قبل الشركة يجب التحقق من صحة وتسجيل براءة الاختراع من قبل المشتري في بلده